Author: Structural Heart Disease Australia

SHDA Research Update – November 2017

Welcome to the monthly SHDA Research Update. Our specialists have selected 3 seminal papers that have been recently published in each speciality (Cardiology, Cardiac Surgery, Cardiac Imaging, Perioperative Medicine).   Cardiology Summarised by Sarah Catchpoole Scally C, et al. Persistent Long-Term Structural, Functional, and Metabolic Changes After Stress-Induced (Takotsubo) Cardiomyopathy. Circulation. 2017 Nov 11. This study challenges the common perception that Takasubo cardiomyopathy is a self-limiting condition. Rather, the authors found persisting impairments, all consistent with a long-term heart failure phenotype. Of 37 patients with a prior diagnosis of Takasubo cardiomyopathy (minimum >12 months, range 13–39, median 20), 88% reported persistent symptoms...

Read More

New 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery

Summarised by Andrew Haymet Authors/Task Force Members. 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. European Journal of Cardio-Thoracic Surgery. 2017 Oct 3.  This joint EACTS/EACTA publication provides a series of evidence based recommendations with regard to patient blood management in cardiac surgery.   Preoperative management There is no association between preoperative prothrombin time (PT) or activated partial thromboplastin time (APTT) and perioperative blood loss or transfusion requirements. The most commonly identified risk factor for postoperative bleeding is a low fibrinogen level. Whilst preoperative fibrinogen levels and thrombin generation assays may be considered to identify patients...

Read More

New 2017 EACTS Guidelines on Perioperative Medication in Adult Cardiac Surgery

Summarised by Andrew Haymet Sousa Uva M, et al. 2017 EACTS Guidelines on Perioperative Medication in Adult Cardiac Surgery. European Journal of Cardio-Thoracic Surgery. 2017 Oct 6.  This publication from EACTS aims to provide an updated guideline focusing on the main pharmacological classes involved in the perioperative management of adult patients undergoing cardiac surgery.   Multidisciplinary decision making It is recommended that the Heart Team discuss the optimal timing of stopping antithrombotic preoperative treatment of patients undergoing cardiac surgery, based on ischaemic and bleeding risk (Class I C).   Antithrombotic management Acetylsalicylic acid (ASA) Preoperatively: In patients on ASA...

Read More

SHDA Research Update – October 2017

Welcome to the monthly SHDA Research Update. Our specialists have selected 3 seminal papers that have been recently published in each speciality (Cardiology, Cardiac Surgery, Cardiac Imaging, Perioperative Medicine).   Cardiology Summarised by Sarah Catchpoole Barbanti M, et al. Transcatheter Mitral Valve Implantation Using the HighLife System. JACC Cardiovasc Interv. 2017 Aug 28;10(16):1662–70.  This paper details the successful first-in-human implantation of the HighLife transcatheter mitral valve system in two patients with severe functional mitral regurgitation. The device consists of two parts (Figure 1) – a subannular ring, which is implanted first via the transfemoral route, followed by deployment of the mitral bioprosthesis...

Read More

SHDA Research Update – September 2017

Welcome to the monthly SHDA Research Update. Our specialists have selected 3 seminal papers that have been recently published in each speciality (Cardiology, Cardiac Surgery, Cardiac Imaging, Perioperative Medicine).   Cardiology Summarised by Sarah Catchpoole Søndergaard L, et al. Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke. N Engl J Med. 2017 Sep 14 Part of a three article series and editorial on patent foramen ovale (PFO), this multi-national, blinded randomised controlled trial assigned patients to either PFO closure with antiplatet therapy (n=441) or to antiplatet therapy alone (n=223) and monitored clinical outcomes over a median follow-up of 3.2 years....

Read More

Recent Tweets

Subscribe